On the detection of excess disease risk in family data
โ Scribed by Jay H. Lubin; Sherri J. Bale; D. C. Rao
- Book ID
- 102224618
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 382 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0741-0395
No coin nor oath required. For personal study only.
โฆ Synopsis
Letters to the Editor
On the Detection of Excess Disease Risk in Family Data
To the Editor: Recently, Chakraborty et a1 [1984] and Tarone [1986] have proposed statistics for testing whether disease occurrence in a pedigree differs from disease patterns in a referent population. They assumed that disease outcome, X, for each individual is a Bernoulli random variable and that affection probability, p, is known. In practice, however, p is usually replaced by the "expected" value, e, which is the cumulative disease rate of a standard population, adjusting for year, sex, and race. Since e is a sum of age-specific disease rates, it can, under certain circumstances, exceed unity and thus cannot be a Bernoulli success probability p. If there is no loss to follow-up, then p can and should be explicitly calculated. If there is loss to follow-up, then p cannot usually be determined, since the standard population contains no information on the loss to follow-up distribution. The purpose of this letter is to highlight these points and to suggest that analyses based on the standardized mortality (morbidity) ratio (SMR) and the related Poisson-based test of no association should prove adequate for most purposes.
Suppose a pedigree has N members. For the ith individual, we observe age at response ti and a variable indicating affection (Xi = 1) or not affection ( X i =0) for the disease of interest. Time to event ti includes time to the cause of interest, death from other causes, loss to follow-up, or termination of study. A goal is to evaluate if the
๐ SIMILAR VOLUMES
It is often of interest to know whether there is increased occurrence of a trait in a pedigree or other structured set of epidemiological data. In answering such questions most current methods use aggregate measures, such as relative risk, that may not relate the outcome for each individual to that